T7	Treatment 0 55	Bevacizumab is a recently developed monoclonal antibody
T8	Treat-Disorder 124 136	angiogenesis
T9	Drug 0 11	Bevacizumab
T5	Potential_therapeutic_event 116 123	inhibit
E1	Potential_therapeutic_event:T5